HIGHLIGHTS
- who: Yujian Xu et al. from the (UNIVERSITY) have published the article: Ferroptosis-related lncRNA signature predicts prognosis and immunotherapy efficacy in cutaneous melanoma, in the Journal: (JOURNAL)
- how: Genetic mutations can affect the tumor response to chemotherapy and targeted therapy therefore the authors investigated the association between the risk model and the efficacy of chemotherapy and targeted therapy drugs in patients with CM.
SUMMARY
Frontiers in Surgery frontiersin.org 10.3389/fsurg.2022.860806 value, the authors classified all patients as high-risk (≥median risk score) or low-risk ( and . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.